1887

Abstract

Summary

The purpose of this study was to define cell-wall components of responsible for activation of human polymorphonuclear leucocytes (PMNL). Metabolic activation of PMNL was determined by chemiluminescence (CL). Purified peptidoglycan (PG) induced a concentration-dependent metabolic burst in PMNL. The minimal concentration needed for CL induction was 1 μg/ml. Comparison between different strains showed variation in the capacity to induce CL in PMNL. Purified PG induced a higher CL response in PMNL than its intact parent strain; this effect was found in all strains. Lipoteichoic acid (LTA), PG stem peptide and muramyldipeptide (MDP) did not induce CL; teichoic acid induced a CL response only at very high concentrations. No differences in CL inducing capacity were found between PG, crude cell walls, and purified cell walls of Sonication of PG strongly diminished CL-inducing capacity. PG treatment with mutanolysin immediately resulted in decreased CL-inducing capacity. Treatment of PG with lytic enzyme (SALE) 10 μg/ml for up to 15 min enhanced the CL response to PMNL; a similar increase in CL was induced by PG treated with SALE at 1 μg/ml for up to 120 min. Beyond these times, a continuous decrease in PG-induced CL was observed. In conclusion, PG was found to be the major cell-wall component of involved in CL induction. Moreover, a minimal fragment size or a specific tertiary structure of PG, or both, is required for metabolic activation of PMNL.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-39-3-196
1993-09-01
2024-11-12
Loading full text...

Full text loading...

/deliver/fulltext/jmm/39/3/medmicro-39-3-196.html?itemId=/content/journal/jmm/10.1099/00222615-39-3-196&mimeType=html&fmt=ahah

References

  1. Fleer A, Verhoef J. New aspects of staphylococcal infections: emergence of coagulase-negative staphylococci as pathogens. Antonie van Leeuwenhoek 1984; 50:729–744
    [Google Scholar]
  2. Anon Coagulase-negative staphylococci. Lancet 1981; 1:139–140
    [Google Scholar]
  3. Ponce de Leon S, Wenzel RP. Hospital-acquired bloodstream infections with Staphylococcus epidermidis. Review of 100 cases. Am J Med 1984; 77:639–644
    [Google Scholar]
  4. Wagner M, Rye M, Wagner B. Electronmicroscopic local ization of peptidoglycan in the cell wall of Streptococcus pyogenes by means of labelled antibodies and lysozyme. In: Seidl PH, Schleifer KH. (eds) Biological properties of peptidoglycan Berlin: W de Gruyter; 1986129–134
    [Google Scholar]
  5. Peterson PK, Wilkinson BJ, Kim Y et al. The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest 1978; 61:597–609
    [Google Scholar]
  6. Dziarski R. Effects of peptidoglycan on the cellular components of the immune system. In: Seidel PH, Schleifer KH. (eds) Biological properties of peptidoglycan Berlin: W de Gruyter; 1986229–247
    [Google Scholar]
  7. Musher DM, Verbrugh HA, Verhoef J. Suppression of phago cytosis and chemotaxis by cell wall components of Staphylococcus aureus. J Immunol 1981; 127:84–88
    [Google Scholar]
  8. Verbrugh HA, van Dijk WC, Peters R, van der Tol ME, Verhoef J. The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the process of complement activation and opsonization. Immunology 1979; 37:615–621
    [Google Scholar]
  9. Wilkinson BJ, Kim Y, Peterson PK, Quie PG, Michael AF. Activation of the complement by cell surface components of Staphylococcus aureus. Infect Immun 1978; 20:388–392
    [Google Scholar]
  10. Aly R, Shinefield HR, Litz C, Maibach HI. Role of teichoic acid in the binding of Staphylococcus aureus to nasal epithelial cells. J Infect Dis 1980; 141:463–465
    [Google Scholar]
  11. Teti G, Chiofalo MS, Tomasello F, Fava C, Mastroeni P. Mediation of Staphylococcus saprophyticus adherence to uroepithelial cells by lipoteichoic acid. Infect Immun 1987; 55:839–842
    [Google Scholar]
  12. Kloos WE, Schleifer KH. Simplified scheme for routine identification of human staphylococcal species. J Clin Microbiol 1975; 1:82–88
    [Google Scholar]
  13. Wicken AJ, Knox KW. Studies on the group F antigen of Lactobacilli: isolation of a teichoic acid-lipid complex from Lactobacillus fermenti NCTC 6991. J Gen Microbiol 1970; 60:293–301
    [Google Scholar]
  14. Stevens P, Winston DJ, Van Dyke K. In vitro evaluation of opsonic and cellular granulocyte function by luminol- dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states. Infect Immun 1978; 22:41–51
    [Google Scholar]
  15. Weksler BB, Hill MJ. Inhibition of leukocyte migration by a staphylococcal factor. J Bacteriol 1969; 98:1030–1035
    [Google Scholar]
  16. Oken MM, Peterson PK, Wilkinson BJ. Endogenous pyrogen production by human blood monocytes stimulated by staphylococcal cell wall components. Infect Immun 1981; 31:208–213
    [Google Scholar]
  17. Spika JS, Peterson PK, Wilkinson BJ et al. Role of peptidoglycan from Staphylococcus aureus in leukopenia, thrombocytopenia, and complement activation associated with bacteremia. J Infect Dis 1982; 146:227–234
    [Google Scholar]
  18. Schleifer KH, Kandler O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 1972; 36:407–477
    [Google Scholar]
  19. Ofek I, Sharon N. Lectinophagocytosis: a molecular mechanism of the recognition between cell surface sugars and lectins in the phagocytosis of bacteria. Infect Immun 1988; 56:539–547
    [Google Scholar]
  20. Kawata S, Takemura T, Yokogawa K, Kotani S. Isolation of bacteriolytic endopeptidase from a strain of Cytophaga and its application to preparation of hydrosoluble polysaccharide peptide from Staphylococcus epidermidis peptidoglycan. Agric Biol Chem 1984; 48:2253–2263
    [Google Scholar]
  21. Kawata S, Takamura T, Yokogawa K. Characterization of two N-acetylmuramidases from Streptomyces globisporum 1829. Agric Biol Chem 1983; 47:1501–1508
    [Google Scholar]
  22. Kaku M, Yagawa K, Nagao S, Tanaka A. Enhanced superoxide anion release from phagocytes by muramyl dipeptide or lipopolysaccharide. Infect Immun 1983; 39:559–564
    [Google Scholar]
  23. Jupin C, Parant M, Chedid L, Damais C. Enhanced oxidative burst without interleukin 1 production by normal human polymorphonuclear leukocytes primed with muramyl dipeptides. Inflammation 1987; 11:153–161
    [Google Scholar]
  24. Forehand JR, Pabst MJ, Phillips WA, Johnston RB. Lipopolysaccharide priming of human neutrophils for an enhanced respiratory burst. Role of intracellular free calcium. J Clin Invest 1989; 83:74–83
    [Google Scholar]
  25. Guthrie LA, McPhail LC, Henson PM, Johnston RB. Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med 1984; 160:1656–1671
    [Google Scholar]
/content/journal/jmm/10.1099/00222615-39-3-196
Loading
/content/journal/jmm/10.1099/00222615-39-3-196
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error